Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295393 · ClinicalTrials.gov registry record
Renin Angiotensin Aldosterone System In Septic Kids
A clinical trial of Sepsis and Acute Kidney Injury Due to Sepsis, sponsored by Northwell Health.
- Recruiting
- Registry status
- 74
- Enrollment target
- 1
- Study location
NCT06295393 is a study of Sepsis and Acute Kidney Injury Due to Sepsis that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 74 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06295393, a study of Sepsis and Acute Kidney Injury Due to Sepsis, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective observational cohort study; pediatric sepsis vs. healthy pediatric subjects and pediatric sepsis with acute kidney injury (AKI) vs without AKI. Blood samples and renal ultrasound will be collected on sequential days for septic subject and one time for the healthy patients. Enzyme-linked immunosorbent assays (ELISA) with be run on serum plasma to compare the renin-angiotensin-aldosterone system (RAAS) between groups.
Conditions Studied
Study Locations (1)
New York
- Cohen Children's Medical Center - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2025-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06295393
The ClinicalTrials.gov registry entry for NCT06295393 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sepsis appearing as the primary indexed condition, and to 0 interventions.
NCT06295393 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06295393 about?
NCT06295393 is a clinical study titled "Renin Angiotensin Aldosterone System In Septic Kids". Prospective observational cohort study; pediatric sepsis vs. healthy pediatric subjects and pediatric sepsis with acute kidney injury (AKI) vs without AKI. Blood samples and renal ultrasound will be collected on sequential days for septic subject and one time for the healthy patients. Enzyme-linke...
What is the current status of trial NCT06295393?
This trial is currently recruiting. The enrollment target is 74 participants. The study started on 2024-01-24. Estimated completion is 2025-06-01.
What conditions does trial NCT06295393 study?
This clinical trial studies the following conditions: Sepsis, Acute Kidney Injury Due to Sepsis, Acute Kidney Injury (Nontraumatic).
Who is sponsoring clinical trial NCT06295393?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295393 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.